Digital Screening for Atrial Fibrillation to Prevent Stroke
Recruiting
N/A
Interventional Study
Atrial Fibrillation (Prevention of Stroke)
Stroke
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 65 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Screening
- Participants needed
- 100,060 (estimated)
- Sponsor
- Medical University Innsbruck · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The Austrian Digital Heart Study is a population-based, siteless, randomized, controlled digital trial testing whether a smartphone-based atrial fibrillation screening and management pathway reduces stroke hospitalizations compared with usual care. Adults aged 65 years or older in Austria are randomized to either a digital intervention using the 'Pulskontrolle' app or to usual care. The interventi…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria
1. Age ≥ 65 years
2. Policyholder in Austria (active unique social insurance number)
3. Written electronic informed consent Exclusion Criteria
a) Currently treated with oral anticoagulation b) Cardiac implanted electronic device (CIED)
Contacts